Antidepressant classes: onset, side effects and stopping questions
Antidepressants are not a ladder from weak to strong. SSRIs, SNRIs, mirtazapine and older classes differ in adverse effects, interactions, withdrawal profile and suitability for other health conditions. Some early change may occur within two weeks, but full benefit often takes longer. Selection and stopping should be planned around the person, the diagnosis and the exact medicine.
Key takeaways
- A shared class does not guarantee identical sleep, appetite, sexual, blood-pressure, heart-rhythm or withdrawal effects.
- Early nausea, restlessness or sleep change may appear before mood improves; worsening agitation, suicidal thoughts or manic symptoms need prompt review.
- Withdrawal can follow missed doses or rapid stopping and can resemble relapse, so the exact medicine and duration matter when planning a gradual reduction.
What does an antidepressant class tell you?
A class describes part of a medicine’s pharmacology, not the full experience of taking it. Singapore’s Agency for Care Effectiveness (ACE) groups SSRIs, SNRIs and newer agents as second-generation antidepressants. It recommends these over tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) for routine first-line medicine treatment of major depressive disorder because older classes have a narrower safety margin and greater potential toxicity.
That does not make every second-generation medicine interchangeable. ACE notes differences in adverse effects, contraindications, interactions and cost, while most efficacy differences between locally registered options are small or uncertain. A previous useful response, another illness, pregnancy, current medicines and the effects a person most wants to avoid can matter more than a class ranking.
| Class or example | Common comparison questions | Important cautions to discuss |
|---|---|---|
| SSRIs: escitalopram, sertraline, fluoxetine, paroxetine | Nausea, sleep, restlessness and sexual effects; interactions; prior response | Bleeding risk, low sodium, serotonin syndrome, mania risk and medicine-specific withdrawal |
| SNRIs: venlafaxine, duloxetine | Similar serotonergic effects plus whether pain symptoms or another indication matters | Blood pressure or heart rate, liver or kidney considerations, interactions and withdrawal |
| Mirtazapine | Whether sleep, appetite or weight effects fit or conflict with the person’s needs | Drowsiness, increased appetite, weight gain and impaired alertness |
| TCAs: amitriptyline and others | Whether there is a specific reason an older medicine is being used | Anticholinergic effects, falls, rhythm risk and greater danger in overdose |
| MAOIs | Specialist use after other options or for selected presentations | Major food and medicine interactions; switching needs specialist planning |
This table is a discussion map, not a self-selection tool. Individual products within a row still differ, and an antidepressant may be prescribed for anxiety, pain or another indication rather than depression.
How long should benefit take?
The current Singapore ACE depression guidance says some symptom improvement may occur as early as two weeks, while full benefit is typically assessed over about 4–12 weeks. NICE advises explaining that, if an antidepressant is going to work, an effect is usually seen within four weeks, alongside an early follow-up for adverse effects and risk.
Those ranges are not a promise and do not mean nothing should happen before the review. Sleep, appetite, agitation, nausea or anxiety can change before mood and functioning improve. Useful monitoring therefore records both benefit and burden: getting out of bed, concentrating, returning to routine, engaging with people and experiencing interest, not only a single daily mood score.
If response is limited, ACE advises checking adherence, ongoing stressors, adverse effects, diagnostic accuracy and medical conditions that can mimic depression before altering treatment. Anaemia, thyroid disease, substance use, bipolar disorder and interacting medicines are examples of issues that can change the next step.
Why do side effects differ within and between classes?
Serotonin effects can produce nausea, diarrhoea, sweating, tremor, sleep disturbance and sexual difficulties, but their pattern and severity vary. The HealthHub escitalopram guide also flags bleeding, low sodium, abnormal rhythm, mania and serotonin syndrome as uncommon but important concerns. SNRIs add noradrenergic effects that can influence pulse or blood pressure in some people.
Mirtazapine has a different profile. HealthHub lists drowsiness, increased appetite and weight gain among its common effects. Those features may influence selection when sleep or low appetite is part of the presentation, but they can be unacceptable for someone who drives early, works around machinery or is already concerned about weight or metabolic health.
TCAs may cause dry mouth, constipation, blurred vision, urinary problems, postural dizziness and sedation. Their cardiac and overdose risks are a major reason they are not routine first-line depression medicines. A small milligram number does not mean a low-risk medicine, and a medicine used at a low dose for pain cannot be compared directly with a depression regimen.
Which early changes need prompt review?
New or worsening thoughts of suicide or self-harm, severe agitation, inability to stay safe, markedly reduced need for sleep, unusually elevated or irritable mood, impulsive behaviour, hallucinations or confusion require prompt assessment. Antidepressants can reveal manic or hypomanic symptoms in someone whose depression is part of bipolar disorder, which changes management.
Urgent assessment is also needed for a suspected overdose, seizure, fainting or a possible severe medicine reaction. Fever with agitation, confusion, heavy sweating and uncontrolled muscle twitching can indicate serotonin syndrome, particularly when serotonergic medicines or supplements have been combined.
St John’s wort is not a harmless add-on. ACE advises against combining it with antidepressants because of serotonin-syndrome risk, and NICE notes that variable preparations can have serious interactions with medicines including hormonal contraceptives, anticoagulants and anticonvulsants. Bring supplements, traditional remedies and non-prescription medicines into the same review as prescriptions.
Why can stopping feel different from relapse?
Antidepressant withdrawal may include dizziness, electric-shock-like sensations, nausea, sleep disturbance, vivid dreams, sweating, irritability, anxiety, low mood and flu-like symptoms. It can follow abrupt stopping, rapid reduction or missed doses. NICE notes that withdrawal risk exists across SSRIs, SNRIs, TCAs and MAOIs, and may be more prominent with medicines such as paroxetine and venlafaxine.
Timing can provide a clue: withdrawal often begins soon after a dose reduction or missed doses, while relapse does not usually appear immediately. The distinction is not always obvious, especially when anxiety and sleep symptoms overlap. Do not test it by repeatedly stopping and restarting.
Singapore’s ACE guidance recommends a gradual reduction when discontinuation is agreed and notes that shorter half-life medicines or longer treatment can require slower tapering. The plan may take weeks or months and should respond to symptoms. A fixed online schedule cannot account for available formulations, prior withdrawal, relapse risk or urgent adverse effects.
What changes the answer?
- The diagnosis and severity. Depression with psychosis, bipolar features, severe anxiety, substance use or immediate self-harm risk needs a different level of care.
- The effect profile that matters most. Sleepiness, insomnia, sexual effects, appetite, weight, pain, blood pressure, falls and driving can change preference.
- Other medicines and remedies. Serotonergic drugs, anticoagulants, NSAIDs, sedatives, stimulants and St John’s wort may create interaction concerns.
- Age, pregnancy and organ function. Older age, pregnancy or breastfeeding, and kidney or liver impairment affect selection and monitoring.
- Past response and withdrawal. A medicine that previously helped or caused difficult effects carries more useful information than a generic class ranking.
- Overdose risk. Pack size and medicine toxicity matter when there is current or previous self-harm risk.
What should you bring to an antidepressant review?
Bring the exact packet, dose label, start date, missed doses, every other medicine or supplement, and a short record of changes in mood, sleep, appetite, anxiety, concentration, sexual function and daily activity. Write down which effects appeared first and whether they followed a dose change.
In Singapore, call 995 if someone is in immediate danger. The national mindline is available 24 hours on 1771, and Samaritans of Singapore provides 24-hour support on 1767. The antidepressants category and major-depressive-disorder condition page can help identify terms on a label, but they cannot choose or stop treatment for an individual.
Sources
- Singapore Agency for Care Effectiveness: Major depressive disorder—achieving and sustaining remission.
- NICE: Depression in adults—treatment and management.
- HealthHub Singapore: Escitalopram medicine guide.
- HealthHub Singapore: Mirtazapine medicine guide.
- HealthHub MindSG: Preventing self-harm and suicide—helplines.
